Up-regulation of type II collagen gene by 17β-estradiol in articular chondrocytes involves Sp1/3, Sox-9, and estrogen receptor α
- 2 August 2014
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 92 (11) , 1179-1200
Abstract
The existence of a link between estrogen deprivation and osteoarthritis (OA) in postmenopausal women suggests that 17β-estradiol (17β-E2) may be a modulator of cartilage homeostasis. Here, we demonstrate that 17β-E2 stimulates, via its receptor human estrogen receptor α 66 (hERα66), type II collagen expression in differentiated and dedifferentiated (reflecting the OA phenotype) articular chondrocytes. Transactivation of type II collagen gene (COL2A1) by ligand-independent transactivation domain (AF-1) of hERα66 was mediated by “GC” binding sites of the −266/−63-bp promoter, through physical interactions between ERα, Sp1/Sp3, Sox9, and p300, as demonstrated in chromatin immunoprecipitation (ChIP) and Re-Chromatin Immuno-Precipitation (Re-ChIP) assays in primary and dedifferentiated cells. 17β-E2 and hERα66 increased the DNA-binding activities of Sp1/Sp3 and Sox-9 to both COL2A1 promoter and enhancer regions. Besides, Sp1, Sp3, and Sox-9 small interfering RNAs (siRNAs) prevented hERα66-induced transactivation of COL2A1, suggesting that these factors and their respective cis-regions are required for hERα66-mediated COL2A1 up-regulation. Our results highlight the genomic pathway by which 17β-E2 and hERα66 modulate Sp1/Sp3 heteromer binding activity and simultaneously participate in the recruitment of the essential factors Sox-9 and p300 involved respectively in the chondrocyte-differentiated status and COL2A1 transcriptional activation. These novel findings could therefore be attractive for tissue engineering of cartilage in OA, by the fact that 17β-E2 could promote chondrocyte redifferentiation. • 17β-E2 up-regulates type II collagen gene expression in articular chondrocytes. • An ERα66/Sp1/Sp3/Sox-9/p300 protein complex mediates this stimulatory effect. • This heteromeric complex interacts and binds to Col2a1 promoter and enhancer in vivo. • Our findings highlight a new regulatory mechanism for 17β-E2 action in chondrocytes. • 17β-E2 might be an attractive candidate for cartilage engineering applications.Keywords
This publication has 59 references indexed in Scilit:
- The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiolProceedings of the National Academy of Sciences, 2009
- The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnoverArthritis Research & Therapy, 2009
- Vascular Endothelial Growth Factor Receptor-2 Expression Is Down-Regulated by 17β-Estradiol in MCF-7 Breast Cancer Cells by Estrogen Receptor α/Sp ProteinsMolecular Endocrinology, 2008
- Production of sex steroid hormones from DHEA in articular chondrocyte of ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Estrogen receptor α and Sp1 regulate progesterone receptor gene expressionMolecular and Cellular Endocrinology, 2003
- SOX9 Exerts a Bifunctional Effect on Type II Collagen Gene (COL2A1) Expression in Chondrocytes Depending on the Differentiation StateDNA and Cell Biology, 2003
- SP3 Represses the SP1-mediated Transactivation of the HumanCOL2A1 Gene in Primary and De-differentiated ChondrocytesJournal of Biological Chemistry, 2001
- Regulation of human COL2A1 gene expression in chondrocytes: identification of C-KROX responsive elements and modulation by phenotype alterationJournal of Biological Chemistry, 2000
- Expression of genes for estrogen receptors α and β in human articular chondrocytesOsteoarthritis and Cartilage, 1999
- Estrogen receptors in cultured rabbit articular chondrocytes: Influence of ageThe Journal of Steroid Biochemistry and Molecular Biology, 1988